The Patent Finder

Sillajen, Inc.

Also on record
Records under this name other than the patents Sillajen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 2 of 2 · Back to Sillajen, Inc.

PatentTitleStatus Expires Confidence
US 9,919,047Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
Lapsed on the fee record
Ended Mar 20, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 20, 2026From the USPTO record
US 9,856,258(5,6-dihydro)pyrimido[4,5-E]indolizines
Surrendered on reissue
Surrendered on reissue Mar 15, 2022 · From the USPTO record
Surrendered on reissueSurrendered on reissue Mar 15, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited